Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Opus Genetics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +24 vs. Q1 2026
- Shares held
- 57.5M
- +12.1M (+26.6%) vs. Q1 2026
- Total value
- $236.4M
- +$32.6M (+16.0%) vs. Q1 2026
- New holders
- 40
- 34 more added
- Sold out
- 16
- 12 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $236.4M |
| Q1 2026 | 79 | $203.8M |
| Q4 2025 | 59 | $55.9M |
| Q3 2025 | 48 | $31.9M |
| Q2 2025 | 43 | $16.5M |
| Q1 2025 | 46 | $14.7M |
| Q4 2024 | 43 | $4.38M |
| Q3 2024 | 38 | $3.32M |
| Q2 2024 | 37 | $4.13M |
| Q1 2024 | 49 | $6.78M |
| Q4 2023 | 50 | $11.2M |
| Q3 2023 | 50 | $12.6M |
| Q2 2023 | 49 | $16.0M |
| Q1 2023 | 41 | $13.0M |
| Q4 2022 | 35 | $10.9M |
| Q3 2022 | 37 | $5.69M |
| Q2 2022 | 38 | $4.62M |
| Q1 2022 | 41 | $6.69M |
| Q4 2021 | 40 | $8.07M |
| Q3 2021 | 30 | $8.62M |
| Q2 2021 | 36 | $5.61M |
| Q1 2021 | 27 | $5.27M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 3,683,429 | $15.1M | 36.33% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 6,029,775 | $24.8M | 0.03% | 00.0% | Unchanged |
| Caligan Partners LP | 6,077,084 | $25.0M | 1.21% | +2,0560.0% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,835,842−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −388,491−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −143,796−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −73,209−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −67,663−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −61,313−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −41,600−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −28,564−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −17,919−100.0% | Sold out |
| Bedel Financial Consulting, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −12,466−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −10,594−100.0% | Sold out |
| Reliant Investment Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −5−100.0% | Sold out |